Cardiology pp 411-415 | Cite as

Impairment of Fibrinolysis as a Risk Factor for Thrombosis

  • D. Collen


The factors generally accepted to be important in thrombus formation are known as Virchow’s triad:1 the vessel wall, the composition of the blood and the flow of the blood in the vessel. The components in the blood which play a role in the pathogenesis of thrombosis are the blood platelets, the coagulation system and the fibrinolytic system.


Plasminogen Activator Fibrinolytic System Hyaline Membrane Disease Postoperative Deep Vein Thrombosis Euglobulin Clot Lysis Time 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R. Virchow, Gesammelte Abhandlungen zur wissenschaftlichen Medizin, Meidinger Sohn und Comp., Frankfurt (1856).Google Scholar
  2. 2.
    J. R. A. Mitchell and C. J. Schwartz, in: “Arterial disease,” Blackwell, Oxford, (1965).Google Scholar
  3. 3.
    T. Astrup, Biological significance of fibrinolysis, Lancet 2:565 (1956).CrossRefGoogle Scholar
  4. 4.
    D. Collen, On the regulation and control of fibrinolysis, Thrombos.Haemostas. 43:77 (1980).Google Scholar
  5. 5.
    B. Wiman and D. Collen, Molecular mechanism of physiological fibrinolysis, Nature 272:549 (1978).PubMedCrossRefGoogle Scholar
  6. 6.
    M. Hoylaerts, D. C. Rijken, H. R. Lijnen, and D. Collen, Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin, J.Biol.Chem. 257:2912 (1982).PubMedGoogle Scholar
  7. 7.
    D. C. Rijken, M. Hoylaerts, and D. Collen, Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator, J.Biol.Chem. 257:2920 (1982).PubMedGoogle Scholar
  8. 8.
    B. Wiman and D. Collen, On the kinetics of the reaction between human antiplasmin and plasmin, Eur.J.Biochem. 84:573 (1978).PubMedCrossRefGoogle Scholar
  9. 9.
    S. Isacson and I. M. Nilsson, Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis, Acta Chir.Scand. 138:313 (1972).PubMedGoogle Scholar
  10. 10.
    I. M. Nilsson, U. Hedner, and S. Isacson, Phenformin and ethyloestrenol in recurrent venous thrombosis, Acta Med.Scand. 198: 107 (1975).PubMedCrossRefGoogle Scholar
  11. 11.
    L. Johansson, U. Hedner, and I. M. Nilsson, A family with thromboembolic disease associated with deficient f ibrinolytic activity in vessel wall, Acta Med.Scand. 203:477 (1978).PubMedCrossRefGoogle Scholar
  12. 12.
    J. K. Clayton, J. A. Anderson, and G. P. McNicol, Preoperative prediction of postoperative deep vein thrombosis, Brit.Med.J. 2:910 (1976).PubMedCrossRefGoogle Scholar
  13. 13.
    I. Rákóczi, D. Chamone, D. Collen, and M. Verstraete, Prediction of postoperative leg vein thrombosis in gynaecological patients, Lancet 1:509 (1978).PubMedCrossRefGoogle Scholar
  14. 14.
    C. M. Ambrus, T. S. Choi, and E. Cunnanan, Prevention of hyaline membrane disease with plasminogen. A cooperative study, JAMA 237: 1837 (1977).PubMedCrossRefGoogle Scholar
  15. 15.
    N. Aoki, M. Moroi, Y. Sakata, N. Yoshida, and M. Matsuda, Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis, J.Clin.Invest. 61: 1186 (1978).PubMedCrossRefGoogle Scholar
  16. 16.
    R. C. Wohl, L. Summaria, and K. C. Robbins, Physiological activation of the human plasminogen variants. Chicago I and Chicago II, J.Biol.Chem. 254:9063 (1979).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • D. Collen
    • 1
  1. 1.Center for Thrombosis and Vascular Research Department of Medical ResearchUniversity of LeuvenBelgium

Personalised recommendations